News

Two studies suggest that they do.

Five novel agents for the treatment of patients with advanced squamous cell carcinoma of the lung will be evaluated in the recently launched Lung-MAP trial, an innovative biomarker-driven study that aims to improve the drug development process while exploring therapeutic options for this challenging malignancy.

According to a new study, most women aged 65 and older with non-metastatic breast cancer adhered to their hormone therapy.

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has shown that electroacupuncture produces significant improvements in fatigue, anxiety, and depression in as little as 8 weeks for early-stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors (AIs).

Genetics may be to blame for an increase in the number of young men diagnosed with prostate cancer, researchers say.

New two drug oral regimen found to be superior to a commonly used regimen.

Researchers now have a better idea of how a mismatch in the DNA repair protein can lead to the development of colorectal cancer.

Rick Bulifant shares his bladder cancer story

Taking the breast cancer journey with someone who's been "in your shoes"

It was the cancer diagnosis of Nancy Davenport-Ennis' friend that inspired her to open both the Patient Advocate Foundation and National Patient Advocate Foundation (NPAF) back in 1996

It happens all the time. A man gets older, but he doesn't think he needs to be checked for prostate cancer. Even if his father or grandfather had prostate cancer, he feels fine, and does not see the need for yearly physical exams. However, the reality is that 1 in 7 American men will be diagnosed with prostate cancer at some point in his lifetime.

A pilot program initiated by UnitedHealthcare involving 5 oncology groups that focused on best treatment practices and health outcomes, rather than the number of drugs that oncologists prescribe, resulted in a 34% reduction in medical costs.

Researchers at the National Cancer Institute (NCI) have found that a negative HPV screening test is better at evaluating cervical cancer risk than a negative Pap test.

FORCE has collaborated with researchers at the University of South Florida and the Michigan Department of Community Health to form the ABOUT Patient-Powered Research Network

Clinical practice guidelines show no agents prevent this side effect.

Cardiac events associated with trastuzumab (Herceptin) are mostly reversible and outweighed by significant extensions in overall survival (OS) and progression-free survival (PFS) for patients with HER2-positive breast cancer

A gel formulation of tamoxifen is equally as effective with fewer side effects when compared with oral tamoxifen in women with ductal carcinoma in situ

This college admissions essay, penned by 17-year-old Samantha Stephens, offers a powerful and poignant reminder of the impact a cancer diagnosis can have on a patient's family and caregivers.

For patients receiving treatment for oral and head and neck cancer, maintaining adequate nutrition is an ongoing challenge.

When my late husband John and I started the Bladder Cancer Advocacy Network (BCAN) in 2005, our goal was not only to raise awareness about bladder cancer, but to change the landscape for this disease by funding research to discover new treatments that will save lives.

The risk for pancreatic cancer dramatically decreases the longer a person takes low-dose aspirin

Meta-analysis finds more research is needed.

Tim Turnham, executive director, Melanoma Research Foundation, provides an overview of some of the services offered by the Melanoma Research Foundation.

Researchers from the nursing school at Case Western Reserve University have found caregivers of terminal cancer patients reported a high degree of satisfaction when they had a team available to them through difficult decisions and end-of-life treatment for their loved one.

Spending all day sitting on the couch to binge watch your favorite television show not only isn't great for your waistline, recent research suggests it could increase your risk for cancer.

Androgen-deprivation therapy (ADT) is a mainstay of treatment for prostate cancer in a number of settings, so managing its side effects is becoming increasingly important for urologists and oncology practitioners in collaboration with primary care physicians.

Everything we know and will learn in the future about hereditary cancer risks, screening, and treatment comes from years of scientific research and the direct participation of thousands of volunteers.

An approach using heat to alleviate the pain commonly associated with bone metastases has proven to be safe and effective in a multicenter phase III clinical trial, yielding a 64% response rate based on self-reported pain scores among patients receiving the noninvasive intervention.